NASDAQ:ARTC - ArthroCare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$2.04
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare's two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It's Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.

Receive ARTC News and Ratings via Email

Sign-up to receive the latest news and ratings for ARTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
Current SymbolNASDAQ:ARTC



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

ArthroCare (NASDAQ:ARTC) Frequently Asked Questions

What is ArthroCare's stock symbol?

ArthroCare trades on the NASDAQ under the ticker symbol "ARTC."

What is the consensus analysts' recommendation for ArthroCare?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ArthroCare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ArthroCare.

Has ArthroCare been receiving favorable news coverage?

News headlines about ARTC stock have trended very positive on Tuesday, InfoTrie reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ArthroCare earned a news impact score of 3.2 on InfoTrie's scale. They also assigned news headlines about the medical device company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are ArthroCare's key executives?

ArthroCare's management team includes the folowing people:
  • Gayle Wiley, Chief Human Resource Officer, Senior Vice President
  • Jean A. Woloszko M.D., Ph.D., Senior Vice President - Research and Development, Chief Technology Officer (Age 56)
  • Richard W. Rew II, Senior Vice President, General Counsel, Secretary (Age 49)
  • Scott Schaffner, Senior Vice President, General Manager - Sports Medicine (Age 44)
  • Fred B. Dinger III, Senior Vice President, General Manager of ENT
  • James L. Pacek, Senior Vice President - Global Markets and Sales Operations (Age 65)
  • Bruce C. Prothro, Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance (Age 52)
  • Fabiana Lacerca-Allen, Independent Director (Age 47)

How do I buy shares of ArthroCare?

Shares of ARTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ArthroCare's official website?

The official website for ArthroCare is

How can I contact ArthroCare?

ArthroCare's mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company can be reached via phone at +1-512-3913900.

MarketBeat Community Rating for ArthroCare (NASDAQ ARTC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  115 (Vote Underperform)
Total Votes:  234
MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote "Outperform" if you believe ARTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel